BrainCapture is differentiated by its explicit focus on affordable, nurse-administered epilepsy EEG in resource-limited settings across Africa and South Asia, a deployment context most EEG companies do not target. With CE Class IIA MDR certification and a 27-channel portable amplifier, it occupies a global-health niche that is commercially smaller but competitively uncontested relative to the ambulatory EEG market in developed economies.